Carbamazepine-10,11-époxide influencing concentrations of carbamazepine measured by Flex® Carbamazepine immuno-assay;Influence de la carbamazépine-10,11-époxyde dans le dosage de la carbamazépine « Dimension Flex® Carbamazepine »

Immuno-Analyse et Biologie Specialisee

Volumn 18, Issue 6, 2003, Pages 354-359

  Lancelin, F ^a   Cattelotte, J ^a   Boyer, C ^a   Mouchet, E ^a   Biset, T ^b   Kraoul, L ^a   Piketty, M L ^a  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

^b Institut Cardiologique J Cartier   (France)

Author keywords

Carbamazepine; Carbamazepine 10,11 epoxide HPLC

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; DRUG METABOLITE;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CONVULSION; CORRELATION ANALYSIS; CROSS REACTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFICACY; DRUG METABOLISM; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 1242273677     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immbio.2003.09.004     Document Type: Article

References (15)

1. Bertilsson L., Tomson T. Clinical pharmacokinetics and pharmalogical effects of carbamazepine and carbamazepine-10,11-epoxide. Clin Pharmacokinet. 11:1986;177-198.
2. Bhatti M.M., Hanson G.D., Schultz L. Simultaneous determination of phenytoin, carbamazepine and 10,11-carbamazepine epoxide in human plasma by high performance liquide chromatography with ultraviolet detection. J Pharm Biomed Anal. 16:1998;1233-1240.
3. Eichelbaum M., Ekbom K., Bertilsson L., Ringberger V.A., Rane A. Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses. Europ J Clin Pharmacol. 8:1975;337-341.
4. Hermida J., Boveda M.D., Vadillo F.J., Tutor J.C. Comparison between the Cobas Integra immunoassay and high-performance liquid chromatography for therapeutic monitoring of carbamazepine. Clin Biochem. 35:2002;251-254.
5. Kerr B.M., Thummel K.E., Wurden C.J., Klein S.M., Kroetz D.L., Gonzalez F.J., et al. Human liver carbamazepine metabolism: role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem Pharmacol. 47:1994;1969-1979.
6. McKauge L., Tyrer J.H., Eadie M.J. Factors influencing simultaneous concentrations of carbamazepine and its epoxide in plasma. Ther Drug Monit. 3:1981;63-70.
7. Miller J.J., Valdes R. Methods for calculating crossreactivity in immunoassays. J Clin Immunoassay. 15:1992;97-107.
8. Parant F, Moulsa M, Gagnieu MC, Lardet G. Á propos de trois cas d'intoxication à l'Atarax: interférence de l'hydroxyzine et de son principal métabolite, la cétirizine, avec l'immunodosage de la carbamazépine par la technique Petinia (Dade Behring). Communication sous forme de poster. Xe Congrès annuel de la Société française de toxicologie analytique. 19-21 juin 2002, Martigny, Suisse.
9. Piketty M.L., Lebtahi R., Dumont A., Chevenne D., Dilouya A. La réaction croisée en immuno-analyse. Immunoanal Biol Spec. 9:1994;285-292.
10. Pisani F., Fazio A., Oteri G., Ruello C., Gitto C., Russo F., et al. Sodium valproate and valpromide: differential interactions with carbamazepine in epileptic patients. Epilepsia. 27:1986;548-552.
11. Pisani F., Caputo M., Fazio A., Oteri G., Russo M., Spina E., et al. Interaction of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine, with valproate: a pharmakokinetic study. Epilepsia. 31:1990;339-342.
12. Rambeck B., May T., Juergens U. Serum concentrations of carbamazepine and its epoxide and diol metabolites in epileptic patients: the influence of dose and comedication. Ther Drug Monit. 9:1987;298-303.
13. Ramsay R.E., McManus D.Q., Guterman A., Briggle T.V., Vazquez D., Perchalski R., et al. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy. Ther Drug Monit. 12:1990;235-241.
14. Shen S., Elin R.J., Soldin S.J. Characterization of cross reactivity by carbamazepine-10,11-epoxide with carbamazepine assays. Clin Biochem. 34:2001;157-158.
15. Spina E., Pisani F., Perucca E. Clinically significant pharmacikinetic drug interactions with carbamazepine. Clin Pharmacokinet. 31:1996;198-214.